SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-015898
Filing Date
2021-08-05
Accepted
2021-08-05 16:42:02
Documents
67
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrtx-20210630.htm   iXBRL 10-Q 1393153
2 EX-5.1 mrtx06302021exhibit51.htm EX-5.1 11914
3 EX-10.1 mrtx06302021exhibit101.htm EX-10.1 600209
4 EX-21.1 mrtx06302021exhibit211.htm EX-21.1 3006
5 EX-31.1 mrtx06302021ex311.htm EX-31.1 14522
6 EX-31.2 mrtx06302021ex312.htm EX-31.2 14307
7 EX-32.1 mrtx06302021ex321.htm EX-32.1 8218
13 image_0a.jpg GRAPHIC 10552
14 image_1.jpg GRAPHIC 8359
  Complete submission text file 0001628280-21-015898.txt   6223417

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20210630.xsd EX-101.SCH 37232
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrtx-20210630_cal.xml EX-101.CAL 51549
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20210630_def.xml EX-101.DEF 141080
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20210630_lab.xml EX-101.LAB 436785
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20210630_pre.xml EX-101.PRE 264443
15 EXTRACTED XBRL INSTANCE DOCUMENT mrtx-20210630_htm.xml XML 893389
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35921 | Film No.: 211149025
SIC: 2834 Pharmaceutical Preparations